Insider Transactions in Q2 2023 at Anika Therapeutics, Inc. (ANIK)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
Sheryl L Conley Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+22.31%
|
-
|
|
Jun 14
2023
|
Gary P Fishetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+23.07%
|
-
|
|
Jun 14
2023
|
John B Henneman Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.84%
|
-
|
|
Jun 14
2023
|
Glenn R. Larsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.65%
|
-
|
|
Jun 14
2023
|
Stephen Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+18.88%
|
-
|
|
Jun 14
2023
|
Jeffery S Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.07%
|
-
|
|
Jun 14
2023
|
Susan L N Vogt Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,500
+17.67%
|
-
|
|
Apr 26
2023
|
Cheryl R Blanchard President, CEO, Director |
SELL
Payment of exercise price or tax liability
|
Direct |
10,900
-8.71%
|
$283,400
$26.34 P/Share
|
|
Apr 26
2023
|
Cheryl R Blanchard President, CEO, Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,575
+16.41%
|
-
|
|
Apr 13
2023
|
Gary P Fishetti Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,858
+45.86%
|
-
|